Stay updated on Acalabrutinib vs Ibrutinib in CLL Clinical Trial
Sign up to get notified when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.

Latest updates to the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page
- ChecktodayChange DetectedAdded a Locations section listing study sites by state (Arizona, California, Florida, Georgia, Illinois, Kansas, Minnesota, Montana, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Texas, Virginia, Washington, Wisconsin) and updated the revision tag from v3.3.2 to v3.3.3.SummaryDifference0.9%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedPublications section updated: new PubMed-linked publications were added on 2025-11-20 and older PubMed entries were removed on 2025-09-02 and 2025-08-29. Entries are automatically populated from PubMed and may or may not pertain to the study.SummaryDifference0.1%

- Check36 days agoChange DetectedThe site-wide government funding notice regarding potential updates and response delays was removed. This notice previously warned that information may not be up to date and that NIH operations could be affected.SummaryDifference0.2%

- Check50 days agoChange DetectedThe observed changes are minor formatting adjustments that do not alter the study's core content (interventions, eligibility criteria, outcomes). To avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check79 days agoChange DetectedUpdate to version v3.2.0 and addition of a government operating status notice; removal of a specific resource topic and older version tag (v3.1.0).SummaryDifference3%

- Check86 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to Acalabrutinib vs Ibrutinib in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.